Eidos Therapeutics is a company that provides Amyloidosis, Medicine, Transthyretin and more. Eidos Therapeutics is headquartered in United States California. Eidos Therapeutics was founded in 2013. and was founded by Isabella Graef, Mamoun Alhamadsheh. Eidos Therapeutics has a total of 57 patents
BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach...